Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

OncoMyx Therapeutics
Phoenix BioScience Center
445 N. Fifth Street
Phoenix, AZ 85004
https://www.oncomyx.com/

OncoMyx Therapeutics, a startup launched from Arizona State University (ASU), develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effective IO complement. The company's MYXV platform, spun out from ASU, is poised to be a best-in-class OV approach, and the top OV team has assembled around MYXV to create important new therapeutic options for cancer patients.

Key Contact
Name
Steve Potts
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
06/05/19 $25,000,000 Series A Boehringer Ingelheim Venture Fund
City Hill Ventures
Delos Capital
Korea Investment Partners
Madison Partners
Xeraya Capital
undisclosed